Subbu Nambi
Stock Analyst at Guggenheim
(4.28)
# 479
Out of 5,022 analysts
46
Total ratings
65.79%
Success rate
13.06%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADPT Adaptive Biotechnologies | Initiates: Buy | $20 | $16.25 | +23.08% | 1 | Sep 30, 2025 | |
| TEM Tempus AI | Maintains: Buy | $80 → $95 | $93.60 | +1.50% | 4 | Sep 26, 2025 | |
| GH Guardant Health | Maintains: Buy | $56 → $67 | $64.25 | +4.28% | 6 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Maintains: Buy | $32 → $36 | $31.19 | +15.42% | 2 | Aug 13, 2025 | |
| DHR Danaher | Reiterates: Buy | $250 | $207.02 | +20.76% | 2 | Jul 23, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $88 → $115 | $122.17 | -5.87% | 1 | Jun 30, 2025 | |
| NEOG Neogen | Maintains: Buy | $13 → $10 | $5.82 | +71.97% | 3 | Jun 30, 2025 | |
| ILMN Illumina | Maintains: Buy | $122 → $114 | $92.44 | +23.32% | 3 | May 9, 2025 | |
| TWST Twist Bioscience | Reiterates: Buy | $50 | $31.56 | +58.43% | 2 | May 6, 2025 | |
| CYRX Cryoport | Reiterates: Buy | $10 | $10.00 | - | 1 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $61.35 | -2.20% | 2 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.92 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $37 | $34.63 | +6.84% | 3 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $36.76 | - | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $200 | $176.51 | +13.31% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $73.10 | - | 1 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $4.31 | +39.21% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.99 | +506.00% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.90 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $149.76 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $22.66 | +10.33% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.75 | - | 1 | Dec 14, 2023 |
Adaptive Biotechnologies
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $16.25
Upside: +23.08%
Tempus AI
Sep 26, 2025
Maintains: Buy
Price Target: $80 → $95
Current: $93.60
Upside: +1.50%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $56 → $67
Current: $64.25
Upside: +4.28%
Caris Life Sciences
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $31.19
Upside: +15.42%
Danaher
Jul 23, 2025
Reiterates: Buy
Price Target: $250
Current: $207.02
Upside: +20.76%
GeneDx Holdings
Jun 30, 2025
Maintains: Buy
Price Target: $88 → $115
Current: $122.17
Upside: -5.87%
Neogen
Jun 30, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $5.82
Upside: +71.97%
Illumina
May 9, 2025
Maintains: Buy
Price Target: $122 → $114
Current: $92.44
Upside: +23.32%
Twist Bioscience
May 6, 2025
Reiterates: Buy
Price Target: $50
Current: $31.56
Upside: +58.43%
Cryoport
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $10.00
Upside: -
Apr 11, 2025
Reiterates: Buy
Price Target: $60
Current: $61.35
Upside: -2.20%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.92
Upside: -
Apr 9, 2025
Maintains: Buy
Price Target: $45 → $37
Current: $34.63
Upside: +6.84%
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $36.76
Upside: -
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $176.51
Upside: +13.31%
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $73.10
Upside: -
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $4.31
Upside: +39.21%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $0.99
Upside: +506.00%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $11.90
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $149.76
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $22.66
Upside: +10.33%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.75
Upside: -